Quick Answer
Acadia Healthcare Company, Inc. reported Diluted EPS of $12.16 per share (loss) for fiscal year 2025.
Acadia Healthcare Company, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$12.16 | -537.4% |
| 2024 | $2.78 | +1258.3% |
| 2023 | -$0.24 | -108.1% |
| 2022 | $2.98 | +41.9% |
| 2021 | $2.10 | +127.7% |
| 2020 | -$7.59 | -712.1% |
| 2019 | $1.24 | +161.7% |
| 2018 | -$2.01 | -187.4% |
| 2017 | $2.30 | +3185.7% |
| 2016 | $0.07 | -95.7% |
| 2015 | $1.64 | +9.3% |
| 2014 | $1.50 | +76.5% |
| 2013 | $0.85 | +60.4% |
| 2012 | $0.53 | +128.5% |
| 2011 | -$1.86 | -631.4% |
| 2010 | $0.35 | +118.7% |
| 2009 | $0.16 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.40 | -45.9% | +21.2% |
| June 30, 2025 | $0.33 | -61.2% | +266.7% |
| March 31, 2025 | $0.09 | -89.2% | -87.8% |
| September 30, 2024 | $0.74 | +131.0% | -12.9% |
| June 30, 2024 | $0.85 | +7.6% | +2.4% |
| March 31, 2024 | $0.83 | +15.3% | +134.7% |
| September 30, 2023 | -$2.39 | -406.4% | -402.5% |
| June 30, 2023 | $0.79 | -10.2% | +9.7% |
- Acadia Healthcare Company, Inc. showed a decrease of -537.4% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, Acadia Healthcare Company, Inc.’s diluted eps has declined by 7700.0% (from $0.16 per share to $12.16 per share (loss)).
- The most recent figure is from Acadia Healthcare Company, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: